<DOC>
	<DOCNO>NCT02474888</DOCNO>
	<brief_summary>The aim investigator ' study evaluate whether monitor serum rituximab level could interest tool follow-up ANCA-associated vasculitis patient . All consecutive patient , hospitalize new diagnosis ANCA-associated vasculitis relapse know ANCA-associated vasculitis , decision start induction regimen rituximab take , include . Serum rituximab level ( along serum anti-rituximab antibody level ) determine ( M+1 M+3 ) correlation clinical outcome M+6 analyze .</brief_summary>
	<brief_title>Pharmacokinetic Study Rituximab Induction Regimen ANCA-associated Vasculitis</brief_title>
	<detailed_description />
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Age &gt; 18 year Granulomatosis polyangiitis microscopic polyangiitis ( accord Chapel Hill criterion ) , without detectable ANCA Decision take start induction regimen rituximab Informed sign study consent form If childbearing potential , female patient use effective method contraception RTX ( rituximab ) treatment 12 month follow RTX treatment stop nobreastfeeding RTX treatment 12 month follow RTX treatment stop Other primary secondary systemic vasculitis Incapacity refusal sign inform consent form Incapacity refusal adhere treatment perform followup examination require study Allergy , document hypersensitivity contraindication medication use present study ( corticosteroid , rituximab ) severe active infection Patient severe heart failure ( stage NYHA IV ) unstable heart disease Pregnancy , except case expect benefit oj treatment seem surpass potential risk Patients active hepatitis B Any live vaccine within four week prior first infusion RTX</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>